Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Hematology Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global Hematology Diagnostics market is set to expand significantly, expected to surge from US$7.6 Billion in 2022 to US$11.9 Billion by 2030. This growth is attributed to a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2022-2030. A comprehensive analysis within the industry underscores the significant rise in demand for Consumables, which are anticipated to grow at a CAGR of 5.3%.
With a keen eye on the market's recovery trajectory post-pandemic, Instruments in Hematology Diagnostics also show robust growth prospects, with a forecasted CAGR of 6.6% over the next eight years. These insights are a part of the latest strategic business report that offers a detailed coverage of the sector's competitive landscape, market growth catalysts, and future trends.
In a geographical lens, the Hematology Diagnostics market sees the U.S. as a significant player, holding an estimation of US$2.1 Billion in 2022. Meanwhile, China is expected to exhibit remarkable growth, with a forecasted 9.2% CAGR, potentially reaching US$2.7 Billion by 2030. Other regions such as Japan and Canada are also set to see healthy growth rates of 3% and 4.8% respectively. European nations contribute to the market expansion, with Germany predicted to grow at a 3.9% CAGR.
Notable Market Dynamics
- The report provides a deep dive into the competitiveness within the industry, featuring key market shares of prominent competitors in the hematology space.
- A breakdown of market presence across diverse geographies, categorized as Strong, Active, Niche, or Trivial, offering a comprehensive view of the global landscape.
- Enhanced by interactive peer-to-peer collaboration, the report ensures dynamic updates that reflect the ever-evolving market scenarios.
- Subscribers gain exclusive access to digital archives and a research platform, enriched with complimentary updates for one year.
The findings revealed in this strategic business report are indispensable for industry stakeholders, investors, and other readers interested in the Hematology Diagnostics sector, providing critical data and analysis for strategic decision-making and investment opportunities.
Advancements in technology, growing incidence of hematological diseases, and increased healthcare expenditure worldwide will play pivotal roles in driving the market forward. The detailed insights offered in the report are essential to understanding the nuances of the market and the strategies employed by the key players within this thriving industry.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 174 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $7.6 Billion |
| Forecasted Market Value (USD) by 2030 | $11.9 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes
- Abbott Laboratories
- Beckman Coulter, Inc.
- F. Hoffmann-La Roche AG
- Mindray Medical International Ltd.
- Siemens Healthineers
- Sysmex Corporation
For more information about this report visit https://www.researchandmarkets.com/r/xkmx30
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
